Expiration date: 04/2025

Indications:

Arterial hypertension (if necessary, combined therapy with perindopril/indapamide and amlodipine).

Contraindications:

Increased sensitivity to the components. Angioedema (angioedema Quincke) in history, associated with the reception of ACE inhibitors. Hereditary / idiopathic angioedema. Bilateral renal artery stenosis, solitary kidney artery stenosis. Severe hypotension (systolic blood PRESSURE less than 90 mm Hg. V.). Shock, including cardiogenic shock. Unstable angina (with the exception of strokes Prinzmetala). Hypokalemia. Obstruction of the left ventricle exit tract. Hemodynamically unstable heart failure after acute myocardial infarction. Renal failure (KK less 60 ml/min). Severe liver failure, including hepatic encephalopathy. Pregnancy and breastfeeding. The age of 18. For more information, see the user manual.

Method of application:

Inside, 1 tablet 1 time a day, preferably in the morning before meals. The dose of the drug Co-Dalneva® is selected after a previous titration of doses of individual components of the drug. The maximum daily dose of Co-Dulneva® is 8 mg of perindopril + indapamide 2.5 mg + 10 mg amlodipine.